Barclays Maintains Underweight on Clorox, Raises Price Target to $130
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) and raises the price target from $122 to $130.

August 05, 2024 | 11:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Lauren Lieberman maintains an Underweight rating on Clorox (NYSE:CLX) and raises the price target from $122 to $130.
The Underweight rating suggests a bearish outlook, but the raised price target indicates some positive expectations. The mixed signals likely result in a neutral short-term impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100